孕鼠维生素D缺乏通过下调PAR1抑制胎盘发育导致胎鼠生长受限

侯雨霏, 韩雨, 孙晓霞, 邱服斌

营养学报 ›› 2025, Vol. 47 ›› Issue (4) : 347-351.

PDF(2160 KB)
PDF(2160 KB)
营养学报 ›› 2025, Vol. 47 ›› Issue (4) : 347-351.
论著

孕鼠维生素D缺乏通过下调PAR1抑制胎盘发育导致胎鼠生长受限

  • 侯雨霏1, 韩雨1, 孙晓霞1, 邱服斌1,2
作者信息 +

VITAMIN D DEFICIENCY IN PREGNANT RATS INHIBITS PLACENTAL DEVELOPMENT LEADING TO FETAL GROWTH RESTRICTION THROUGH DOWNREGULATION OF PAR1 EXPRESSION

  • HOU Yu-fei1, HAN Yu1, SUN Xiao-xia1, QIU Fu-bin1,2
Author information +
文章历史 +

摘要

目的 探究妊娠期维生素D缺乏(vitamin D deficiency,VDD)通过调节PAR1表达,引起胎盘发育不良,最终导致胎儿生长受限的发生机制。方法 根据体质量将4 w龄雌性SD大鼠随机分为两组,每组10只,对照组(Ctrl)饲喂标准饲料,VDD组饲喂维生素D(vitamin D,VD)缺乏饲料。饲喂8 w后与正常雄性SD大鼠进行合笼。妊娠第18 日(gestational day,GD18)时,将两组雌鼠进行麻醉后处死,收集样本,采用ELISA、Western blot检测相关指标。结果 孕前及妊娠GD18时,Ctrl组大鼠的血清25(OH)D浓度分别为(20.37±5.03)ng/ml和(9.09±2.96)ng/ml,VDD组大鼠的血清25(OH)D浓度分别为(13.62±4.55)ng/ml和(5.34±1.63)ng/ml,VDD组大鼠孕前、GD18时血清25(OH)D水平均显著低于Ctrl组(P<0.01或P<0.05);GD18时,VDD组大鼠孕期体重增长量显著低于Ctrl组(P<0.01),胎盘组织中VDR、DBP、CYP27B1蛋白表达水平显著下调(P<0.01),25(OH)D、1,25(OH)2D水平显著降低(P<0.05),胎盘直径、胎盘重量均显著低于Ctrl组(P<0.01),胎盘组织MMP2蛋白表达水平显著下调(P<0.05),而E-cadherin蛋白表达水平显著上调(P<0.05),胚胎着床数、活胎数、胚胎重量、冠臀长均显著低于Ctrl组(P<0.01),吸收胎数显著增多(P<0.01)。与Ctrl组相比,VDD组孕鼠胎盘PAR1蛋白表达水平显著下调(P<0.01)。结论 当母体妊娠期VDD时,胎盘PAR1表达水平显著下调,胎盘发育障碍,胎鼠发育迟缓。

Abstract

Objective To explore the mechanism by which maternal vitamin D deficiency during pregnancy impairs placental development and leads to fetal growth restriction by regulating PAR1 expression. Methods Female Sprague-Dawley (SD) rats aged four weeks were randomly allocated into two groups according to their body weight, with 10 rats in each group: the control group (Ctrl), fed a standard diet, and the vitamin D deficiency group (VDD), fed a vitamin D-deficient diet. After 8 weeks of feeding, the rats were mated with normal male SD rats. On day 18 of gestation, both groups of female rats were euthanized under anesthesia, and samples were collected for detection of relevant indicators via ELISA and Western blot analysis. Results Before pregnancy and on gestational day 18 (GD18), the serum 25(OH)D concentrations in the Ctrl group were (20.37 ± 5.03) ng/ml and (9.09 ± 2.96) ng/ml, respectively, while in the VDD group, they were (13.62 ± 4.55) ng/ml and (5.34 ± 1.63) ng/ml, respectively. The serum 25(OH)D levels in the VDD group were significantly lower than those in the Ctrl group both before pregnancy and on GD18 (P<0.01 or P<0.05). On GD18, the weight gain during pregnancy in the VDD group was significantly lower than that in the Ctrl group (P<0.01). Compared to the Ctrl group, the protein expression levels of VDR, DBP, and CYP27B1 in the placental tissue of the VDD group were significantly downregulated (P<0.01), and the levels of 25(OH)D and 1,25(OH)2D were significantly reduced (P<0.05). The placental diameter and weight in the VDD group were significantly lower than those in the Ctrl group (P<0.01). The expression levelof MMP2 protein was significantly downregulated (P<0.05), while the expression level of E-cadherin protein was significantly upregulated (P<0.05). The number of embryo implantations, live fetuses, embryo weight, and crown-rump length in the VDD group were significantly lower than those in the Ctrl group (P<0.01), and the number of resorbed fetuses was significantly increased (P<0.01). Compared to the Ctrl group, the expression level of PAR1 protein in the placenta of the VDD group was significantly downregulated (P<0.01). Conclusion Maternal vitamin D deficiency during gestation significantly downregulates placental PAR1 expression, leading to placental developmental disorders and fetal growth retardation.

关键词

维生素D(VD) / PAR1 / 胎盘发育 / 宫内生长受限

Key words

vitamin D (VD) / PAR1 / placental development / intrauterine growth restriction

引用本文

导出引用
侯雨霏, 韩雨, 孙晓霞, 邱服斌. 孕鼠维生素D缺乏通过下调PAR1抑制胎盘发育导致胎鼠生长受限[J]. 营养学报. 2025, 47(4): 347-351
HOU Yu-fei, HAN Yu, SUN Xiao-xia, QIU Fu-bin. VITAMIN D DEFICIENCY IN PREGNANT RATS INHIBITS PLACENTAL DEVELOPMENT LEADING TO FETAL GROWTH RESTRICTION THROUGH DOWNREGULATION OF PAR1 EXPRESSION[J]. Acta Nutrimenta Sinica. 2025, 47(4): 347-351
中图分类号: R151.2   

参考文献

[1] Zhang H, Wang S, Tuo L, et al. Relationship between maternal vitamin D levels and adverse outcomes[J]. Nutrients, 2022, 14: 4230.
[2] Chen YH, Fu L, Hao JH, et al. Influent factors of gestational vitamin D deficiency and its relation to an increased risk of preterm delivery in Chinese population[J]. Sci Rep, 2018, 8: 3608.
[3] 段涛, 杨慧霞, 胡娅莉, 等. 胎儿生长受限专家共识(2019版)[J]. 中国产前诊断杂志, 2019, 11: 78–98.
[4] Miliku K, Vinkhuyzen A, Blanken LM, et al. Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and risks of adverse birth outcomes[J]. Am J Clin Nutr, 2016, 103: 1514–1522.
[5] Abdallah HR, Abdelrazek AA, Youness ER, et al. Assessment of vitamin status; A, E and D in Egyptian neonates with IUGR: a cross sectional study[J]. BMC Pediatr, 2024, 24: 144.
[6] Raia-Barjat T, Sarkis C, Rancon F, et al. Vitamin D deficiency during late pregnancy mediates placenta-
associated complications[J]. Sci Rep, 2021, 11: 20708.
[7] Boire A, Covic L, Agarwal A, et al. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells[J]. Cell, 2005, 120: 303–313.
[8] Dai C, Lin X, Qi Y, et al. Vitamin D3 improved hypoxia-induced lung injury by inhibiting the complement and coagulation cascade and autophagy pathway[J]. BMC Pulm Med, 2024, 24: 9.
[9] Even-Ram SC, Grisaru-Granovsky S, Pruss D, et al. The pattern of expression of protease-activated receptors (PARs) during early trophoblast development[J]. J Pathol, 2003, 200: 47–52.
[10] Chassen S, Jansson T.Complex, coordinated and highly regulated changes in placental signaling and nutrient transport capacity in IUGR[J]. BBA-MOL Basis Dis, 2020, 1866: 165373.
[11] 王煚楠, 徐佳丽, 赵艺敏, 等. 维生素D缺乏经Hippo-YAP信号通路抑制胎盘发育诱发胎儿宫内生长受限[J]. 营养学报, 2022, 44: 270–275.
[12] 乔瑜, 王煚楠, 韩雨, 等. 抑制Hippo-YAP信号通路的激活对维生素D缺乏所致大鼠不良妊娠结局的改善作用[J]. 营养学报, 2024, 46: 34–39.
[13] 吴婷婷, 杨帆, 常珂, 等. 埃克替尼联合二甲双胍对耐药非小细胞肺癌H1975细胞的抗肿瘤作用[J]. 中国新药与临床杂志, 2024, 43: 600–606.
[14] Olmos-Ortiz A, Avila E, Durand-Carbajal M, et al. Regulation of calcitriol biosynthesis and activity: Focus on gestational vitamin D deficiency and adverse pregnancy outcomes[J]. Nutrients, 2015, 7: 443–480.
[15] Vestergaard AL, Andersen MK, Olesen RV, et al. High-dose vitamin D supplementation significantly affects the placental transcriptome[J]. Nutrients, 2023, 15: 5032.
[16] Sun C, Groom KM, Oyston C, et al. The placenta in fetal growth restriction: What is going wrong?[J]. Placenta, 2020, 96: 10–18.
[17] Vestergaard AL, Justesen S, Volqvartz T, et al. Vitamin D insufficiency among Danish pregnant women-prevalence and association with adverse obstetric outcomes and placental vitamin D metabolism[J]. Acta Obstet Gyn Scan, 2021, 100: 480–488.
[18] Chen YH, Liu ZB, Ma L, et al. Gestational vitamin D deficiency causes placental insufficiency and fetal intrauterine growth restriction partially through inducing placental inflammation[J]. J Steroid Biochem Mol Biol, 2020, 203: 105733.
[19] Saluja S, Sugathan N, Krishnamurthy R, et al. Impact of vitamin D deficiency on gestational diabetes and pregnancy outcomes across diverse ethnic groups: a retrospective cohort study[J]. Nutrients, 2025, 17: 565.
[20] Kothari A, Flick MJ. Coagulation signaling through PAR1 as a therapeutic target in pancreatic ductal adenocarcinoma[J]. Int J Mol Sci, 2021, 22: 5138.
[21] Shukla V, Moreno-Irusta A, Varberg KM, et al. NOTUM-mediated WNT silencing drives extravillous trophoblast cell lineage development[J]. PNAS, 2024, 121: e2403003121.
[22] Huang QT, Chen JH, Hang LL, et al. Activation of PAR-1/NADPH oxidase/ROS signaling pathways is crucial for the thrombin-induced sFlt-1 production in extravillous trophoblasts: possible involvement in the pathogenesis of preeclampsia[J]. Cell Physiol Biochem, 2015, 35: 1654–1662.
[23] Grisaru‐Granovsky S, Kumar Nag J, Zakar L, et al. PAR1&2 driven placenta EVT invasion act via LRP5/6 as coreceptors[J]. FASEB J, 2020, 34: 15701–15717.

基金

山西省回国留学人员科研资助项目(No.2022-114); 山西省基础研究计划项目(No.202203021211227)

PDF(2160 KB)

Accesses

Citation

Detail

段落导航
相关文章

/